| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Vandebroek Sophie V. is a Director at RVTY, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 13 sales.
Our model assigns Vandebroek Sophie V. a below-average insider score of 38/100, based on 4 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -19.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | IDXX Idexx Laboratories, Inc. | Director | Sale+OE | 1,464 | $628.62 | $920,293.11 | -69.3% | -12.8% | - | |
| May 9, 2025 | IDXX Idexx Laboratories Inc /de | Director | Sale+OE | 1,279 | $491.34 | $628,425.27 | -52.3% | +32.2% | - | |
| Nov 27, 2024 | IDXX Idexx Laboratories Inc /de | Director | Sell | 344 | $420.44 | $144,629.64 | -27.5% | +9.0% | +78.5% | |
| Mar 5, 2024 | IDXX Idexx Laboratories Inc /de | Director | Sale+OE | 1,404 | $562.98 | $790,427.01 | -53.6% | -11.8% | -21.7% | |
| May 4, 2023 | IDXX Idexx Laboratories Inc /de | Director | Sale+OE | 2,187 | $469.02 | $1,025,739.96 | -71.5% | +10.6% | +2.4% | |
| Feb 12, 2021 | IDXX Idexx Laboratories Inc /de | Director | Sale+OE | 3,046 | $538.20 | $1,639,357.20 | -47.8% | - | - | |
| Feb 18, 2020 | IDXX Idexx Laboratories Inc /de | Director | Sale+OE | 7,568 | $286.89 | $2,171,202.44 | -69.5% | - | - | |
| Aug 5, 2019 | IDXX Idexx Laboratories Inc /de | Director | Sale+OE | 9,044 | $263.86 | $2,386,336.27 | -49.6% | - | - | |
| Aug 3, 2018 | IDXX Idexx Laboratories Inc /de | Director | Sale+OE | 3,265 | $240.64 | $785,695.48 | -27.0% | - | - |